Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_assertion type Assertion NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_head.
- NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_provenance.
- NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_assertion evidence source_evidence_literature NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_provenance.
- NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_assertion SIO_000772 2356863 NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_provenance.
- NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_assertion wasDerivedFrom befree-20150227 NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_provenance.
- NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_assertion wasGeneratedBy ECO_0000203 NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_provenance.